Degradation of Newly Synthesized Polypeptides by Ribosome-Associated RACK1/c-Jun N-Terminal Kinase/Eukaryotic Elongation Factor 1A2 Complex

REFERENCES

• Kramer G, Boehringer D, Ban N, Bukau B. 2009. The ribosome as a platform for cotranslational processing, folding, and targeting of newly synthesized proteins. Nat. Struct. Mol. Biol. 16:589–597.
   PubMed Web of Science ®Google Scholar
• Jha S, Komar AA. 2011. Birth, life, and death of nascent polypeptide chains. Biotechnol. J. 6:623–640.
   PubMedGoogle Scholar
• Brandt F, Carlson LA, Hartl FU, Baumeister W, Grunewald K. 2010. The three-dimensional organization of polyribosomes in intact human cells. Mol. Cell 39:560–569.
   PubMedGoogle Scholar
• van den Berg B, Ellis RJ, Dobson CM. 1999. Effects of macromolecular crowding on protein folding and aggregation. EMBO J. 18:6927–6933.
   PubMed Web of Science ®Google Scholar
• Netzer WJ, Hartl FU. 1997. Recombination of protein domains facilitated by cotranslational folding in eukaryotes. Nature 388:343–349.
   PubMed Web of Science ®Google Scholar
• Nicola AV, Chen W, Helenius A. 1999. Cotranslational folding of an alphavirus capsid protein in the cytosol of living cells. Nat. Cell Biol. 1:341–345.
   PubMed Web of Science ®Google Scholar
• Sherman MY, Goldberg AL. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15–32.
   PubMed Web of Science ®Google Scholar
• Wiedmann B, Sakai H, Davis TA, Wiedmann M. 1994. A protein complex required for signal-sequence-specific sorting and translocation. Nature 370:434–440.
   PubMedGoogle Scholar
• Hotokezaka Y, Tobben U, Hotokezaka H, Van Leyen K, Beatrix B, Smith DH, Nakamura T, Wiedmann M. 2002. Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides. J. Biol. Chem. 277:18545–18551.
   PubMedGoogle Scholar
• Saito K, Kobayashi K, Wada M, Kikuno I, Takusagawa A, Mochizuki M, Uchiumi T, Ishitani R, Nureki O, Ito K. 2010. Omnipotent role of archaeal elongation factor 1α (EF1α) in translational elongation and termination, and quality control of protein synthesis. Proc. Natl. Acad. Sci. U. S. A. 107:19242–19247.
   PubMedGoogle Scholar
• Chuang SM, Chen L, Lambertson D, Anand M, Kinzy TG, Madura K. 2005. Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol. Cell. Biol. 25:403–413.
   PubMed Web of Science ®Google Scholar
• Dimitrova LN, Kuroha K, Tatematsu T, Inada T. 2009. Nascent peptide-dependent translation arrest leads to Not4p-mediated protein degradation by the proteasome. J. Biol. Chem. 284:10343–10352.
   PubMedGoogle Scholar
• Nillegoda NB, Theodoraki MA, Mandal AK, Mayo KJ, Ren HY, Sultana R, Wu K, Johnson J, Cyr DM, Caplan AJ. 2010. Ubr1 and Ubr2 function in a quality control pathway for degradation of unfolded cytosolic proteins. Mol. Biol. Cell 21:2102–2116.
   PubMed Web of Science ®Google Scholar
• Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770–774.
   PubMed Web of Science ®Google Scholar
• Turner GC, Varshavsky A. 2000. Detecting and measuring cotranslational protein degradation in vivo. Science 289:2117–2120.
   PubMed Web of Science ®Google Scholar
• Sha Z, Brill LM, Cabrera R, Kleifeld O, Scheliga JS, Glickman MH, Chang EC, Wolf DA. 2009. The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol. Cell 36:141–152.
   PubMedGoogle Scholar
• Karin M. 1998. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci. 851:139–146.
   PubMed Web of Science ®Google Scholar
• Gutierrez GJ, Tsuji T, Chen M, Jiang W, Ronai ZA. 2010. Interplay between Cdh1 and JNK activity during the cell cycle. Nat. Cell Biol. 12:686–695.
   PubMed Web of Science ®Google Scholar
• Topisirovic I, Gutierrez GJ, Chen M, Appella E, Borden KL, Ronai ZA. 2009. Control of p53 multimerization by Ubc13 is JNK-regulated. Proc. Natl. Acad. Sci. U. S. A. 106:12676–12681.
   PubMed Web of Science ®Google Scholar
• Gandin V, Brina D, Marchisio PC, Biffo S. 2010. JNK inhibition arrests cotranslational degradation. Biochim. Biophys. Acta 1803:826–831.
   PubMedGoogle Scholar
• Grosso S, Volta V, Vietri M, Gorrini C, Marchisio PC, Biffo S. 2008. Eukaryotic ribosomes host PKC activity. Biochem. Biophys. Res. Commun. 376:65–69.
   PubMedGoogle Scholar
• Bhoumik A, Jones N, Ronai Z. 2004. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc. Natl. Acad. Sci. U. S. A. 101:4222–4227.
   PubMedGoogle Scholar
• Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. 2008. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat. Cell Biol. 10:1324–1332.
   PubMed Web of Science ®Google Scholar
• Gandin V, Miluzio A, Barbieri AM, Beugnet A, Kiyokawa H, Marchisio PC, Biffo S. 2008. Eukaryotic initiation factor 6 is rate-limiting in translation, growth, and transformation. Nature 455:684–688.
   PubMed Web of Science ®Google Scholar
• Laine A, Topisirovic I, Zhai D, Reed JC, Borden KL, Ronai Z. 2006. Regulation of p53 localization and activity by Ubc13. Mol. Cell. Biol. 26:8901–8913.
   PubMed Web of Science ®Google Scholar
• Chamberlain JP. 1979. Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Anal. Biochem. 98:132–135.
   PubMed Web of Science ®Google Scholar
• Kieft JS, Zhou K, Jubin R, Doudna JA. 2001. Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 7:194–206.
   PubMed Web of Science ®Google Scholar
• Grosso S, Volta V, Sala LA, Vietri M, Marchisio PC, Ron D, Biffo S. 2008. PKCβII modulates translation independently from mTOR and through RACK1. Biochem. J. 415:77–85.
   PubMed Web of Science ®Google Scholar
• Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z. 2005. RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19:309–320.
   PubMed Web of Science ®Google Scholar
• Werlen G, Jacinto E, Xia Y, Karin M. 1998. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101–3111.
   PubMed Web of Science ®Google Scholar
• Lopez-Bergami P, Ronai Z. 2008. Requirements for PKC-augmented JNK activation by MKK4/7. Int. J. Biochem. Cell Biol. 40:1055–1064.
   PubMedGoogle Scholar
• Fuchs SY, Tappin I, Ronai Z. 2000. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation. J. Biol. Chem. 275:12560–12564.
   PubMedGoogle Scholar
• Liu J, Lin A. 2005. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 15:36–42.
   PubMed Web of Science ®Google Scholar
• Sengupta J, Nilsson J, Gursky R, Spahn CM, Nissen P, Frank J. 2004. Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat. Struct. Mol. Biol. 11:957–962.
   PubMed Web of Science ®Google Scholar
• Yu Y, Ji H, Doudna JA, Leary JA. 2005. Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES-bound complexes. Protein Sci. 14:1438–1446.
   PubMed Web of Science ®Google Scholar
• Coyle SM, Gilbert WV, Doudna JA. 2009. Direct link between RACK1 function and localization at the ribosome in vivo. Mol. Cell. Biol. 29:1626–1634.
   PubMed Web of Science ®Google Scholar
• Wojtaszek PA, Heasley LE, Siriwardana G, Berl T. 1998. Dominant-negative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J. Biol. Chem. 273:800–804.
   PubMedGoogle Scholar
• Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–1037.
   PubMed Web of Science ®Google Scholar
• Wu S, Hu Y, Wang JL, Chatterjee M, Shi Y, Kaufman RJ. 2002. Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem. 277:18077–18083.
   PubMed Web of Science ®Google Scholar
• Rabl J, Leibundgut M, Ataide SF, Haag A, Ban N. 2011. Crystal structure of the eukaryotic 40S ribosomal subunit in complex with initiation factor 1. Science 331:730–736.
   PubMed Web of Science ®Google Scholar
• Mateyak MK, Kinzy TG. 2010. eEF1A: thinking outside the ribosome. J. Biol. Chem. 285:21209–21213.
   PubMed Web of Science ®Google Scholar
• Jackson RJ, Hellen CU, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell. Biol. 11:113–127.
   PubMed Web of Science ®Google Scholar
• Alkalaeva EZ, Pisarev AV, Frolova LY, Kisselev LL, Pestova TV. 2006. In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3. Cell 125:1125–1136.
   PubMed Web of Science ®Google Scholar
• Eggers DK, Welch WJ, Hansen WJ. 1997. Complexes between nascent polypeptides and their molecular chaperones in the cytosol of mammalian cells. Mol. Biol. Cell 8:1559–1573.
   PubMed Web of Science ®Google Scholar
• Perry RP, Kelley DE. 1968. Messenger RNA-protein complexes and newly synthesized ribosomal subunits: analysis of free particles and components of polyribosomes. J. Mol. Biol. 35:37–59.
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda AR. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9:537–549.
   PubMed Web of Science ®Google Scholar
• Rosenzweig R, Osmulski PA, Gaczynska M, Glickman MH. 2008. The central unit within the 19S regulatory particle of the proteasome. Nat. Struct. Mol. Biol. 15:573–580.
   PubMedGoogle Scholar
• Ye Y, Meyer HH, Rapoport TA. 2001. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414:652–656.
   PubMed Web of Science ®Google Scholar
• Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar-Nun S. 2002. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 22:626–634.
   PubMed Web of Science ®Google Scholar
• Kuroha K, Akamatsu M, Dimitrova L, Ito T, Kato Y, Shirahige K, Inada T. 2010. Receptor for activated C kinase 1 stimulates nascent polypeptide-dependent translation arrest. EMBO Rep. 11:956–961.
   PubMedGoogle Scholar
• Steitz TA. 2008. A structural understanding of the dynamic ribosome machine. Nat. Rev. Mol. Cell. Biol. 9:242–253.
   PubMed Web of Science ®Google Scholar
• Hartl FU, Bracher A, Hayer-Hartl M. 2010. Molecular chaperones in protein folding and proteostasis. Nature 475:324–332.
   Google Scholar
• Gonen H, Smith CE, Siegel NR, Kahana C, Merrick WC, Chakraburtty K, Schwartz AL, Ciechanover A. 1994. Protein synthesis elongation factor EF-1α is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc. Natl. Acad. Sci. U. S. A. 91:7648–7652.
   PubMed Web of Science ®Google Scholar
• Ametzazurra A, Larrea E, Civeira MP, Prieto J, Aldabe R. 2008. Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene 27:7296–7306.
   PubMed Web of Science ®Google Scholar
• Yi CH, Pan H, Seebacher J, Jang IH, Hyberts SG, Heffron GJ, Vander Heiden MG, Yang R, Li F, Locasale JW, Sharfi H, Zhai B, Rodriguez-Mias R, Luithardt H, Cantley LC, Daley GQ, Asara JM, Gygi SP, Wagner G, Liu CF, Yuan J. 2011. Metabolic regulation of protein N-α-acetylation by Bcl-xL promotes cell survival. Cell 146:607–620.
   PubMedGoogle Scholar
• Starheim KK, Arnesen T, Gromyko D, Ryningen A, Varhaug JE, Lillehaug JR. 2008. Identification of the human N(α)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression. Biochem. J. 415:325–331.
   PubMedGoogle Scholar
• Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM. 2002. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31:301–305.
   PubMed Web of Science ®Google Scholar
• Ruest LB, Marcotte R, Wang E. 2002. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J. Biol. Chem. 277:5418–5425.
   PubMed Web of Science ®Google Scholar
• Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z. 2007. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11:447–460.
   PubMedGoogle Scholar
• Kulkarni G, Turbin DA, Amiri A, Jeganathan S, Andrade-Navarro MA, Wu TD, Huntsman DG, Lee JM. 2007. Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer Res. Treat. 102:31–41.
   PubMedGoogle Scholar
• Pinke DE, Kalloger SE, Francetic T, Huntsman DG, Lee JM. 2008. The prognostic significance of elongation factor eEF1A2 in ovarian cancer. Gynecol. Oncol. 108:561–568.
   PubMed Web of Science ®Google Scholar
• Yam AY, Xia Y, Lin HT, Burlingame A, Gerstein M, Frydman J. 2008. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat. Struct. Mol. Biol. 15:1255–1262.
   PubMed Web of Science ®Google Scholar